Your browser doesn't support javascript.
loading
Immunogenetic variations predict immune-related adverse events for PD-1/PD-L1 inhibitors.
Xin, Zhaodan; You, Liting; Na, Feifei; Li, Jin; Chen, Min; Song, Jiajia; Bai, Ling; Chen, Jie; Zhou, Juan; Ying, Binwu.
Afiliación
  • Xin Z; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, PR China.
  • You L; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, PR China; Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041,
  • Na F; Department of Thoracic Cancer, West China Hospital, Sichuan University, Chengdu, 610041, PR China.
  • Li J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, PR China.
  • Chen M; Department of Laboratory Medicine, The First Affiliated Hospital of Hainan Medical College, Haikou, Hainan Province 570100, PR China.
  • Song J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, PR China.
  • Bai L; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, PR China.
  • Chen J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, PR China. Electronic address: chenjie_wch@163.com.
  • Zhou J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, PR China. Electronic address: zhoujuan39@wchscu.cn.
  • Ying B; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, PR China. Electronic address: yingbinwu@scu.edu.cn.
Eur J Cancer ; 184: 124-136, 2023 05.
Article en En | MEDLINE | ID: mdl-36917924

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article